Inventor
ROTH BRUCE D
US36 patents
⚠️ This page may combine multiple inventors who share the name “ROTH BRUCE D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
WARNER LAMBERT CO
35 patentsUS5273995ADec 28, 1993
[R-(R*R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl-3-phenyl-4-[(phenylamino) carbonyl]- 1H-pyrrole-1-heptanoic acid, its lactone form and salts thereof
WARNER LAMBERT CO1,008 citations99
US4681893AJul 21, 1987
Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
WARNER LAMBERT CO672 citations99
US5324483AJun 28, 1994
Apparatus for multiple simultaneous synthesis
WARNER LAMBERT CO400 citations98
US5280126AJan 18, 1994
Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
WARNER LAMBERT CO134 citations98
US5245047ASep 14, 1993
Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
WARNER LAMBERT CO136 citations98
US5216174AJun 1, 1993
Process for trans-6-[12-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
WARNER LAMBERT CO163 citations98
US5149837ASep 22, 1992
Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
WARNER LAMBERT CO154 citations98
US5124482AJun 23, 1992
Process for trans-6-(2-substituted-pyrrol-1-yl)alkyl)pyran-2-one inhibitors of cholesterol synthesis
WARNER LAMBERT CO174 citations98
US5097045AMar 17, 1992
Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
WARNER LAMBERT CO166 citations98
US5003080AMar 26, 1991
Process for trans-6-(2-(substituted-pyrrol-1-yl)alkyl)pryan-2-one inhibitors of cholesterol synthesis
WARNER LAMBERT CO240 citations98
US4647576AMar 3, 1987
Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis
WARNER LAMBERT CO299 citations97
US5015644AMay 14, 1991
Antihyperlipidemic and antiatherosclerotic urea and carbamate compounds
WARNER LAMBERT CO77 citations96
US5612002AMar 18, 1997
Apparatus and method for multiple simultaneous synthesis
WARNER LAMBERT CO59 citations95
US4906624AMar 6, 1990
6-(((Substituted)pyridin-3-yl)alkyl)-and alkenyl)-tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
WARNER LAMBERT CO62 citations95
US5385929AJan 31, 1995
[(Hydroxyphenylamino) carbonyl] pyrroles
WARNER LAMBERT CO301 citations93
US4957940ASep 18, 1990
Bicyclo heptane and bicyclo octane substituted inhibitors of cholesterol synthesis
WARNER LAMBERT CO41 citations93
US4906657AMar 6, 1990
Bicyclo heptane and bicyclo octane substituted inhibitors of cholesterol synthesis
WARNER LAMBERT CO47 citations93
US4735958AApr 5, 1988
Trans-6-[2-[2-(substituted-phenyl)-3- (or 4-) heteroaryl-5-substituted-1H-pyrrol-1-yl]-ethyl]tetrahydro-4-hydroxy-2H-pyran-2-one inhibitors of cholesterol biosynthesis
WARNER LAMBERT CO33 citations93
US5366987ANov 22, 1994
Isoxazolyl-substituted alkyl amide ACAT inhibitors
WARNER LAMBERT CO22 citations92
US5102893AApr 7, 1992
Trans-6-(2-(n-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl- or ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
WARNER LAMBERT CO23 citations92
US4997837AMar 5, 1991
6-(((substituted)pyridin-3-yl)alkyl)-and alkenyl)-tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
WARNER LAMBERT CO52 citations92
US4957971ASep 18, 1990
Trans-6-(2-(N-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl)-or ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
WARNER LAMBERT CO24 citations92
US4929620AMay 29, 1990
5-pyrimidinyl-3,5-dihydroxy-6-heptenoic acid compounds useful as inhibitors of cholesterol biosynthesis
WARNER LAMBERT CO50 citations92
US4761419AAug 2, 1988
6-(((substituted)quinolinyl)ethyl)-and ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
WARNER LAMBERT CO33 citations92
US4716175ADec 29, 1987
Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase
WARNER LAMBERT CO43 citations92
US5593967AJan 14, 1997
Cholecystokinin antagonists, their preparation and therapeutic use
WARNER LAMBERT CO22 citations91
US5489611AFeb 6, 1996
Method for lowering plasma levels of lipoprotein (a)
WARNER LAMBERT CO36 citations90
US5331006AJul 19, 1994
Amino acid analogs as CCK antagonists
WARNER LAMBERT CO21 citations90
US4808621AFeb 28, 1989
Trans-6-[2-(N-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl]- or ethenyl]tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
WARNER LAMBERT CO16 citations74
US5441975AAug 15, 1995
Pyrazolo-substituted alkyl amide acat inhibitors
WARNER LAMBERT CO8 citations73
US5278326AJan 11, 1994
Substituted beta-ketoamide ACAT inhibitors
WARNER LAMBERT CO8 citations73
US5254589AOct 19, 1993
Sulfonyl urea and carbamate ACAT inhibitors
WARNER LAMBERT CO7 citations73
US4868185ASep 19, 1989
6-[[Substituted)pyrimidinyl)ethyl]- and ethenyl]tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
WARNER LAMBERT CO18 citations73
US4751229AJun 14, 1988
Treating fungal infections with substituted-(6-(tetrahydro-4-hydroxy-2-oxo-2H-pyran-2-yl)ethyl)- or ethenyl)pyrazoles
WARNER LAMBERT CO8 citations73
US4743605AMay 10, 1988
Saturated fatty acid amides as inhibitors of acyl-coa:cholesterol acyltransferase
WARNER LAMBERT CO5 citations62